A detailed history of Point72 (Difc) LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 189,965 shares of BSX stock, worth $19.6 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
189,965
Previous 16,436 1055.79%
Holding current value
$19.6 Million
Previous $1.47 Billion 1205.38%
% of portfolio
0.79%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$89.38 - $106.18 $15.5 Million - $18.4 Million
173,529 Added 1055.79%
189,965 $19.2 Billion
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $1.37 Million - $1.5 Million
16,436 New
16,436 $1.47 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.